Botox and Jeuveau are both FDA-approved botulinum toxin type A neuromodulators that relax the muscles behind frown lines.
Botox and Jeuveau are both FDA-approved botulinum toxin type A neuromodulators that relax the muscles behind frown lines. At the molecular level Jeuveau is the closest match to Botox of any alternative — the same ~900 kDa complex, dosed 1:1 — so the results are very similar. The real differences come down to price, track record, and a slightly faster onset. Here’s the full comparison, then how to choose.
Botox and Jeuveau are both FDA-approved botulinum toxin type A neuromodulators that relax the muscles behind frown lines. At the molecular level Jeuveau is the closest match to Botox of any alternative — the same ~900 kDa complex, dosed 1:1 — so the results are very similar. The real differences come down to price, track record, and a slightly faster onset. Here’s the full comparison, then how to choose.
Both are botulinum toxin type A injectables that temporarily relax muscles to soften dynamic wrinkles, both are FDA-approved with comparable safety and efficacy, and neither can be reversed — each wears off over time. Both are muscle relaxers, not volumizers: for lost volume you’d want dermal fillers instead, as covered in Botox vs dermal fillers.
This is the headline. Because Jeuveau doses 1:1 with Botox, its lower per-unit price flows straight through to the treatment total. National 2026 averages put Botox around $14–$16 per unit and Jeuveau around $8–$12, so a standard 20-unit frown-line treatment runs roughly $280–$320 with Botox versus $200–$280 with Jeuveau — a typical gap of about $60–$100. That adds up if you come in 3–4 times a year or treat multiple areas, but it’s small enough that you shouldn’t leave a provider you trust just to chase it. See the full breakdown in the Botox cost guide.
Duration is essentially the same — both last about 3–4 months. Onset is where Jeuveau has a slight edge: about half of Jeuveau patients see softening in two days, versus 3–7 for Botox, with peak effect for both around two weeks. If you want markedly longer duration, that’s a different product — Daxxify lasts about twice as long (see Botox vs Daxxify).
Botox has 30+ years of clinical evidence and is FDA-approved for many areas — frown lines, forehead lines, crow’s feet, neck bands — plus numerous medical uses (migraine, excessive sweating, and more). Jeuveau is approved only for frown lines and only for aesthetics, with a shorter history. For most cosmetic frown-line treatments that distinction doesn’t change the result, but if you want a product with the deepest evidence base or you also have a therapeutic need, Botox has the edge.
Because Jeuveau shares Botox’s complex size, the two have similar, predictable diffusion — there’s no dramatic “spread” difference between them. (That contrasts with Dysport, which diffuses more and suits larger areas — see Botox vs Dysport.) Some injectors still develop a personal preference for one over the other in specific areas, but for frown lines they behave very alike.
As the same drug class, their side-effect profiles are very similar — mostly mild and temporary: headache, injection-site reactions, and occasional eyelid droop if the toxin spreads beyond the target. Both carry the same FDA class warning about toxin spread, which hasn’t been a meaningful concern at cosmetic facial doses. The risk profile mirrors Botox’s side effects and differs from filler side effects. The single biggest safety variable is the injector, not the brand.
Yes, easily — it’s one of the simplest switches because the dosing is 1:1 and most patients notice no perceptible difference. If you want to compare them fairly, wait until your current treatment fully wears off (about four months) before trying the other. Neither is reversible, so there’s no undoing a result — it simply fades, and you can switch back next time.
A common question is whether alternating toxins helps avoid “resistance” — the rare situation where the body forms antibodies that blunt a neuromodulator’s effect. In practice, true resistance is uncommon at cosmetic facial doses, and switching between Botox and Jeuveau doesn’t meaningfully change that small theoretical risk, since both are full-complex type A toxins. The more reliable ways to keep results strong are using an appropriate dose, not over-treating, and spacing sessions at least three months apart — not brand-hopping. If you ever notice your usual dose working less well, that’s a conversation to have with your injector rather than a reason to assume resistance.
Match the toxin to your priorities:
Lean Jeuveau if: you’re treating standard cosmetic areas and want to save 20–30%, or you like that it’s purpose-built for aesthetics and may act a touch faster.
Lean Botox if: you want the longest track record, you also have a therapeutic need (migraine, sweating), or you already get consistent results you trust.
Both are excellent in skilled hands, and you can try each over time. Read more on the Botox and Jeuveau hubs, then find and compare qualified injectors near you.
If you’ve never had a neuromodulator, either is a fine starting point — both are well-tolerated and last the same 3–4 months, so a result you dislike fades quickly. Some first-timers like Jeuveau’s lower price for “trying it out,” while others prefer Botox’s long track record for their first experience. If you’re an experienced patient who already knows your ideal Botox dose, switching to Jeuveau is straightforward thanks to the 1:1 dosing — your injector keeps the same unit plan. Either way, start conservatively; you can always add more at a two-week follow-up.
Remember these only treat movement lines. For lost volume — flat cheeks, thin lips, or under-eye hollows — you want fillers, not a toxin: lip filler for lips, or a brand like Juvederm or Restylane (compared in Juvederm vs Restylane) for cheeks, each with its own longevity and cost. Many people combine a toxin for movement lines with filler for volume in one plan.